The Antitrust Review of the Americas 2018

Canada: Pharmaceuticals

19 September 2017

Ongoing expansion and development in the pharmaceutical sector is shaping, and transforming, the competitive landscape globally. The industry's markedly dynamic nature is reflected in a range of activity, from the development of innovative products that are redefining pharmaceutical markets to large-scale mergers with potential competitive effects in multiple jurisdictions. Not surprisingly, this has attracted the attention of competition authorities worldwide.

Interested in becoming a GCR author? Please contact our Insight Manager.

Get in touch